Samuel Saks, M.D.

Samuel Saks, M.D., Clinical Development Advisor

Dr. Saks serves as our Clinical Development Advisor. His leadership in drug development spans decades. Prior to his work with Protagonist, Dr. Saks served as Chief Development Officer and board member at Auspex Pharmaceuticals until the time of its acquisition by Teva Pharmaceuticals. Before his tenure at Auspex, Dr. Saks was a co-founder of Jazz Pharmaceuticals where he also served as Chief Executive Officer. Earlier in his career, Dr. Saks held positions as company group chairman of ALZA Corporation and member of the Johnson & Johnson Pharmaceutical Operating Committee. Dr. Saks has also held leadership and management positions at Schering-Plough, Xoma and Genentech. Dr. Saks serves on the boards of directors of Quanta Therapeutics and Hinge Bio. Dr. Saks received a B.S. in Biology and his M.D. from the University of Illinois.